08:45 AM EDT, 08/26/2025 (MT Newswires) -- Charles River Laboratories International ( CRL ) said Tuesday it has joined the EASYGEN Consortium, an EU-backed initiative to improve CAR-T cell therapy production, affordability, and access.

A collaboration between 18 academic, research, industry and clinic partners across eight countries, the Easy Workflow Integration for Gene Therapy Consortium targets to develop a fully automated, hospital-based platform able to manufacture personalized cell therapies within 24 hours, Charles River said.